Relmada Therapeutics Ownership | Who Owns Relmada Therapeutics?
Relmada Therapeutics Ownership Summary
Relmada Therapeutics is owned by 15.98% institutional investors, 16.99% insiders, and 67.03% retail investors. Vanguard group is the largest institutional shareholder, holding 4.16% of RLMD shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.57% of its assets in Relmada Therapeutics shares.
RLMD Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Relmada Therapeutics | 15.98% | 16.99% | 67.03% |
| Sector | Healthcare Stocks | 486.50% | 11.08% | -397.59% |
| Industry | Biotech Stocks | 304.14% | 11.08% | -215.23% |
| Idea | Psychedelic Stocks List | 41.93% | 14.87% | 43.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Vanguard group | 1.26M | 4.16% | $653.49K |
| Driehaus capital management | 740.01K | 2.23% | $444.23K |
| Blackrock | 573.31K | 1.90% | $1.72M |
| Acadian asset management | 619.48K | 1.87% | $371.00K |
| Blackrock funding, inc. /de | 508.00K | 1.53% | $304.95K |
| Advisorshares investments | 396.51K | 1.19% | $238.03K |
| Geode capital management | 302.84K | 1.00% | $157.52K |
| Deutsche bank ag\ | 224.85K | 0.75% | $116.92K |
| Ubs group | 215.14K | 0.71% | $111.87K |
| Bank of america corp /de/ | 207.97K | 0.69% | $623.91K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Advisorshares investments | 396.51K | 0.04% | $238.03K |
| Spotlight asset group | 20.00K | 0.04% | $60.00K |
| Apricus wealth | 47.46K | 0.02% | $28.49K |
| Adar1 capital management | 130.00K | 0.01% | $78.04K |
| Parsons capital management inc/ri | 163.34K | 0.01% | $98.05K |
| Rbf capital | 163.26K | 0.00% | $98.01K |
| Ikarian capital | 40.27K | 0.00% | $24.17K |
| Bedel financial consulting | 10.00K | 0.00% | $30.00K |
| Driehaus capital management | 740.01K | 0.00% | $444.23K |
| Mgo one seven | 100.00K | 0.00% | $60.03K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Driehaus capital management | 740.01K | 0.00% | 740.01K |
| Marshall wace, llp | 154.57K | 0.00% | 154.57K |
| Renaissance | 164.51K | 0.00% | 138.63K |
| Adar1 capital management | 130.00K | 0.01% | 130.00K |
| Advisorshares investments | 396.51K | 0.04% | 120.00K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Deep track capital, lp | - | - | -674.83K |
| Acadian asset management | 619.48K | 0.00% | -608.45K |
| Palo alto investors lp | - | - | -495.15K |
| Vestal point capital, lp | - | - | -490.00K |
| Opaleye management | - | - | -480.00K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Driehaus capital management | 740.01K | 0.00% | 740.01K | $444.23K |
| Marshall wace, llp | 154.57K | 0.00% | 154.57K | $92.74K |
| Adar1 capital management | 130.00K | 0.01% | 130.00K | $78.04K |
| Lmr partners llp | 55.10K | 0.00% | 55.10K | $33.08K |
| Xtx topco | 46.04K | 0.00% | 46.04K | $27.64K |
Sold Out
| Holder | Change |
|---|---|
| Blackston financial advisory group | -2.00 |
| Innealta capital | -5.00 |
| Smartleaf asset management | -35.00 |
| Qube research | -56.00 |
| Larson financial group | -100.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 47 | 6.82% | 5,303,149 | -14.73% | 15 | 3.82% | 17 | 41.67% | 12 | -14.29% |
| Mar 31, 2025 | 44 | -15.38% | 6,219,493 | -25.95% | 20 | 2.64% | 12 | -36.84% | 14 | -33.33% |
| Dec 31, 2024 | 20 | -73.68% | 5,351,011 | -56.77% | 17 | 1.05% | 6 | -70.00% | 8 | -68.00% |
| Sep 30, 2024 | 76 | -9.52% | 12,376,687 | -8.70% | 41 | 2.03% | 20 | -4.76% | 25 | -21.88% |
| Jun 30, 2024 | 83 | -15.31% | 13,556,139 | -5.26% | 44 | 1.99% | 21 | -48.78% | 31 | 24.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard US Total Market Shares ETF | 851.92K | 2.57% | - |
| Vanguard Total Stock Mkt Idx Inv | 803.29K | 2.42% | -48.63K |
| Franklin Biotechnology Discv A(acc)USD | 623.80K | 2.07% | -221.90K |
| AdvisorShares Psychedelics ETF | 425.60K | 1.28% | - |
| Franklin Biotechnology Discovery A | 336.31K | 1.11% | -120.09K |
| Vanguard Institutional Extnd Mkt Idx Tr | 256.25K | 0.77% | -97.37K |
| Horizons Psychedelic Stock ETF | 227.04K | 0.75% | -36.13K |
| Fidelity Extended Market Index | 158.18K | 0.48% | -413.00 |
| Bridgeway Ultra-Small Company | 100.18K | 0.33% | - |
| Fidelity Enhanced Small Cap ETF | 92.92K | 0.31% | 1.75K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| May 16, 2025 | Kelly Paul Edward | Chief Operating Officer | Buy | $86.06K |
| May 19, 2025 | Shenouda Maged | Chief Financial Officer | Buy | $43.69K |
| May 20, 2025 | Shenouda Maged | Chief Financial Officer | Buy | $31.42K |
| May 16, 2025 | Shenouda Maged | Chief Financial Officer | Buy | $22.10K |
| May 16, 2025 | Ence Chuck | CA and CO | Buy | $103.33K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | 8 | - |
| 2024 Q4 | - | - |
| 2024 Q3 | 8 | - |
| 2024 Q2 | - | - |
| 2024 Q1 | 9 | - |
RLMD Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools